We analyzed the relationship between TFAP2 family proteins and the clinical stage of bladder cancer patients, and found that TFAP2C protein was positively correlated with the worse clinical stage of patients, while TFAP2B showed the opposite trend (Figure 1b). This evidence concerns the gene TFAP2A and urinary bladder carcinoma.